Karen Mahoney - 19 Feb 2025 Form 3 Insider Report for Vericel Corp (VCEL)

Role
Chief Human Resources Officer
Signature
/s/ Sean Flynn, as Attorney-in-Fact for Karen Mahoney
Issuer symbol
VCEL
Transactions as of
19 Feb 2025
Net transactions value
$0
Form type
3
Filing time
19 Feb 2025, 16:05:20 UTC
Next filing
24 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VCEL Stock Option (right to buy) 19 Feb 2025 Common Stock 75,000 $51.58 Direct F1
holding VCEL Restricted Stock Unit 19 Feb 2025 Common Stock 10,500 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options began vesting on July 22, 2024. On the first anniversary of the date of grant, July 22, 2025, 25% of the options shall vest and become exercisable, with the remaining 75% vesting in equal quarterly installments over three (3) years thereafter.
F2 Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation.
F3 These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on July 22, 2025. The remaining RSUs will vest in annual installments on July 22, 2026, July 22, 2027, and July 22, 2028, respectively.
F4 No expiration date for this type of award.